在怀孕期间对症状性SARS-CoV-2感染的反应中增强胎儿血液形成
Mansour Alkobtawi1, Qui Trung Ngô1, Nicolas Chapuis2,3
1Université Paris Cité, CNRS UMR 8104, INSERM U1016, Institut Cochin, Cutaneous Biology Lab, Paris, France.
Communications medicine
|December 11, 2023
概括
母亲的COVID-19症状引发胎儿的压力造血,其特征是红状腺细胞特征和带血液中的活性缺氧通路. 这种反应有助于胎儿适应母亲的感染,并减少氧气供应.
科学领域:
- 围产期免疫学 围产期免疫学
- 胎儿血液形成 胎儿血液形成
- 在SARS-CoV-2的研究中.
背景情况:
- 孕妇和胎儿容易受到呼吸道病原体的影响.
- 胎儿对SARS-CoV-2感染的反应需要进一步调查.
研究的目的:
- 为了研究胎儿对母体SARS-CoV-2感染的反应.
- 分析带血细胞的转录组和表型.
主要方法:
- 研究了患有或没有SARS-CoV-2感染的孕妇的带血细胞.
- 分析了转录组和表型特征.
主要成果:
- 有症状的孕产妇COVID-19与带血中的红状腺细胞特征相关.
- 观察到胎儿红色球原体的扩张,并增加了克隆性.
- 从有症状的母亲的带血细胞中激活缺氧通路.
结论:
- 症状性母体COVID-19诱导胎儿血液形成反应没有垂直SARS-CoV-2传播.
- 这种反应很可能是胎儿适应母亲感染和缺氧的机制.
- 表明胎儿应激造血作为对母体SARS-CoV-2感染的反应.
更多相关视频
08:45Quantitating Iron Transport Across the Mouse Placenta In Vivo Using Nonradioactive Iron Isotopes
Published on: May 10, 2022
2.0K
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
847
相关概念视频
Overview of Hematopoiesis
4.0K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.0K
Role of Hematopoietic Growth Factors
1.4K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.4K
Development of Immunocompetence
312
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
312
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Hematopoiesis
5.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.3K
Teratogenicity
2.5K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.5K
